Overview

Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.

IR Nav

Company Profile

4 Science Park
New Haven, CT 06511

1.203.787.7888

1.203.901.1289

info@precipiodx.com

Today

Intraday stock chart for prpo

Leadership

Ilan Danieli

Founder & CEO

Carl Iberger

CFO

Stephen Miller

Chief Commercial Officer

Zaki Sabet

Chief Operating Officer

Ayman Mohamed

VP R&D

View Management Team

Past Six Months

6 month stock chart for prpo

Investor Relations

CORE IR
Scott Gordon
President
377 Oak Street
Garden City, NY 11530
516.222.2560
www.coreir.com
scottg@coreir.com

Transfer Agent

Wells Fargo Shareholder Services
1110 Centre Pointe Curve
Suite 101
St. Paul, MN 55120
800.468.9716
http://www.wellsfargo.com
stocktransfer@wellsfargo.com

Auditors

Marcum LLP
Michael K. Brooder
750 3rd Avenue, 11th Floor
New York, NY 10017
860.760.0610
http://www.marcumllp.com
michael.brooder@marcumllp.com

Corporate Counsel

Goodwin Procter LLP
Daniel A. Lang
The New York Times Building
620 Eighth Avenue
New York, NY 10018-1405
O: 212 459 7095
F: 646 558 4131
DLang@goodwinlaw.com

Subscribe to IR news and filing alerts

You can opt out at any time. We do not share or sell your info.